Filter by
Subscribe to A New Newsletter: “My Mind Mood & Microbes” to Discover more about the Microbiota-Gut-Brain AxisAs a co-founding partner with Winclove of the Mind, Mood & Microbes (MMM) International Conference on the Microbiota-Gut-Brain axis, Lallemand Health Solutions proudly supports the launch of myMMM (myMindMoodMicrobes) a newsletter dedicated to bringing the latest gut-brain research to a […]
Jul 4, 2024
Leading Microbiome and Probiotics Research ForwardOn World Microbiome Day, let’s celebrate the multifaceted and groundbreaking actions of our research and development group of 40+ members, led by Sylvie Binda, as they advance microbiome and probiotics research for human health. Contributing to Collective Intelligence Efforts We […]
Jun 27, 2024
We’re Hiring a Scientific Communication ManagerReporting to the Preclinical and Clinical Research Director, the Scientific Communication Manager will play a crucial role in communicating our research findings, through different materials. Responsibilities ▪ Content development: Produce high quality scientific content including research articles (Peer-reviewed papers) and […]
Jun 25, 2024
Having IMPACTT 2024: The Rosell® Institute for Microbiome and Probiotics Renews Platinum SponsorshipThe Rosell® Institute for Microbiome and Probiotics by Lallemand is pleased to announce the renewal of its platinum sponsorship for the Canadian microbiome symposium, Having IMPACTT. This marks the fourth consecutive year of their support. The upcoming event, Having IMPACTT […]
May 29, 2024
Lallemand Health Solutions’ SciX Event Gathers Scientists from Around the World To Discuss Probiotic InnovationMirabel, Canada, April 10, 2024 – Renowned scientists from across the globe convened in Montreal last week for the 13th edition of Lallemand Health Solutions’ Scientific Exchange event. This gathering provided a dynamic platform for sharing innovative scientific discoveries. The conference program featured poster […]
May 2, 2024
MEDILAC-S: A PROMISING ADJUVANT IN IBS MANAGEMENTA comprehensive systematic review and meta-analysis have underscored the potential of Medilac-S, a combination of Bacillus subtilis R0179 and Enterococcus faecium R0026; non-commercially known as IBacilluS+, as an effective adjuvant to conventional irritable bowel syndrome (IBS) therapies. The newly published […]
Dec 19, 2023
New Review Highlights B. lactis Lafti® B94 Beneficial Effects in Infant and Children’s Gut HealthA new comprehensive review reaffirmed the significant benefits of the probiotic bacterial strain B. lactis Lafti® B94, whether used alone or as a synbiotic, for promoting gut health in infants and children. The review emphasizes on the strain’s robust safety […]
Nov 7, 2023
New Study Reveals Promising Results for Helicobacter pylori Eradication with Lacidofil®A new study highlights the potential of Lacidofil® as an adjuvant to standard therapy as an effective approach for Helicobacter pylori eradication. “Backed by over 29 positive clinical trials with over 1,000 participants and pre-clinical scientific evidence, Lacidofil® has consistently […]
Nov 2, 2023
Having IMPACTT 2023: The Rosell® Institute for Microbiome and Probiotics Renews Its Platinum SponsorshipThe Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a third year in a row. Having IMPACTT 3: Advancing Microbiome Research will take place from July 10 to […]
Jul 3, 2023
The International Conference on Microbiome-Gut-Brain Axis Is Back!As a co-founding partner, Lallemand Health Solutions proudly presents the fourth edition of the Mind, Mood & Microbes International conference on Microbiome-Gut-Brain axis, which will take place in Amsterdam, the Netherlands, on 10-11 May 2023. The event will gather an […]
May 1, 2023